4.6 Article

X Chromosome-Linked CNVs in Male Infertility: Discovery of Overall Duplication Load and Recurrent, Patient-Specific Gains with Potential Clinical Relevance

Journal

PLOS ONE
Volume 9, Issue 6, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0097746

Keywords

-

Funding

  1. Tuscan Regional Health Research Program
  2. Spanish Ministry of Health [FIS-11/02254]
  3. PRIN
  4. European Commission - Reproductive Biology Early Research Training (REPROTRAIN) [289880]

Ask authors/readers for more resources

Introduction: Spermatogenesis is a highly complex process involving several thousand genes, only a minority of which have been studied in infertile men. In a previous study, we identified a number of Copy Number Variants (CNVs) by high-resolution array-Comparative Genomic Hybridization (a-CGH) analysis of the X chromosome, including 16 patient-specific X chromosome-linked gains. Of these, five gains (DUP1A, DUP5, DUP20, DUP26 and DUP40) were selected for further analysis to evaluate their clinical significance. Materials and Methods: The copy number state of the five selected loci was analyzed by quantitative-PCR on a total of 276 idiopathic infertile patients and 327 controls in a conventional case-control setting (199 subjects belonged to the previous a-CGH study). For one interesting locus (intersecting DUP1A) additional 338 subjects were analyzed. Results and Discussion: All gains were confirmed as patient-specific and the difference in duplication load between patients and controls is significant (p = 1.65 x 10(-4)). Two of the CNVs are private variants, whereas 3 are found recurrently in patients and none of the controls. These CNVs include, or are in close proximity to, genes with testis-specific expression. DUP1A, mapping to the PAR1, is found at the highest frequency (1.4%) that was significantly different from controls (0%) (p = 0.047 after Bonferroni correction). Two mechanisms are proposed by which DUP1A may cause spermatogenic failure: i) by affecting the correct regulation of a gene with potential role in spermatogenesis; ii) by disturbing recombination between PAR1 regions during meiosis. This study allowed the identification of novel spermatogenesis candidate genes linked to the 5 CNVs and the discovery of the first recurrent, X-linked gain with potential clinical relevance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Transplantation

Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players

Andrea Domingo-Gallego, Marc Pybus, Gemma Bullich, Monica Furlano, Laia Ejarque-Vila, Laura Lorente-Grandoso, Patricia Ruiz, Gloria Fraga, Mercedes Lopez Gonzalez, Juan Alberto Pinero-Fernandez, Lidia Rodriguez-Pena, Isabel Llano-Rivas, Raquel Saez, Anna Bujons-Tur, Gema Ariceta, Guirado Lluis, Roser Torra, Elisabet Ars

Summary: Genetic testing of 460 patients with early-onset CKD showed a global diagnostic yield of 65%, with cystic kidney diseases and tubulopathies having higher diagnostic rates. Seven genes accounted for the majority of genetically diagnosed patients.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Review Obstetrics & Gynecology

A systematic review of the validated monogenic causes of human male infertility: 2020 update and a discussion of emerging gene-disease relationships

Brendan J. Houston, Antoni Riera-Escamilla, Margot J. Wyrwoll, Albert Salas-Huetos, Miguel J. Xavier, Liina Nagirnaja, Corinna Friedrich, Don F. Conrad, Kenneth Aston, Csilla Krausz, Frank Tuttelmann, Moira K. O'Bryan, Joris A. Veltman, Manon S. Oud

Summary: Research has shown a significant genetic component in male infertility, particularly monogenic causes. The field had been slow in adopting next-generation sequencing technologies and lacked clear statements on validated causes of human male infertility. Through clinical validity assessment, 120 genes were identified to be moderately, strongly or definitively linked to 104 infertility phenotypes.

HUMAN REPRODUCTION UPDATE (2022)

Article Urology & Nephrology

Guidelines for Genetic Testing and Management of Alport Syndrome

Judy Savige, Beata S. Lipska-Zietkiewicz, Elizabeth Watson, Jens Michael Hertz, Constantinos Deltas, Francesca Mari, Pascale Hilbert, Pavlina Plevova, Peter Byers, Agne Cerkauskaite, Martin Gregory, Rimante Cerkauskiene, Danica Galesic Ljubanovic, Francesca Becherucci, Carmela Errichiello, Laura Massella, Valeria Aiello, Rachel Lennon, Louise Hopkinson, Ania Koziell, Adrian Lungu, Hansjorg Martin Rothe, Julia Hoefele, Miriam Zacchia, Tamara Nikuseva Martic, Asheeta Gupta, Albertien van Eerde, Susie Gear, Samuela Landini, Viviana Palazzo, Laith al-Rabadi, Kathleen Claes, Anniek Corveleyn, Evelien Van Hoof, Micheel van Geel, Maggie Williams, Emma Ashton, Hendica Belge, Elisabet Ars, Agnieszka Bierzynska, Concetta Gangemi, Alessandra Renieri, Helen Storey, Frances Flinter

Summary: Genetic testing for pathogenic COL4A3?5 variants is crucial for investigating persistent hematuria and suspected inherited kidney diseases. Even in cases where a heterozygous pathogenic COL4A3 or COL4A4 is suspected, experts recommend genetic testing and cascade testing of family members to reduce the risk of kidney dysfunction. Testing for variants in the COL4A3?5 genes is also recommended for other kidney conditions such as proteinuria, steroid-resistant nephrotic syndrome, IgA glomerulonephritis, and kidney failure of unknown cause.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Multidisciplinary Sciences

A de novo paradigm for male infertility

M. S. Oud, R. M. Smits, H. E. Smith, F. K. Mastrorosa, G. S. Holt, B. J. Houston, P. F. de Vries, B. K. S. Alobaidi, L. E. Batty, H. Ismail, J. Greenwood, H. Sheth, A. Mikulasova, G. D. N. Astuti, C. Gilissen, K. McEleny, H. Turner, J. Coxhead, S. Cockell, D. D. M. Braat, K. Fleischer, K. W. M. D'Hauwers, E. Schaafsma, L. Nagirnaja, D. F. Conrad, C. Friedrich, S. Kliesch, K. I. Aston, A. Riera-Escamilla, C. Krausz, C. Gonzaga-Jauregui, M. Santibanez-Koref, D. J. Elliott, L. E. L. M. Vissers, F. Tuettelmann, M. K. O'Bryan, L. Ramos, M. J. Xavier, G. W. van der Heijden, J. A. Veltman

Summary: This study examines the role of de novo mutations in severe male infertility. Through trio-based exome sequencing, the researchers identified a significant enrichment of loss-of-function de novo mutations in infertile men. They also identified a new candidate gene, RBM5, which is associated with male infertility. This study provides evidence for the importance of de novo mutations in male infertility and identifies potential genetic causes.

NATURE COMMUNICATIONS (2022)

Editorial Material Andrology

ANDRONET: A new European network to boost research coordination, education and public awareness in andrology

Rafael Oliva, Csilla Krausz, Ewa Rajpert-De Meyts

ANDROLOGY (2022)

Article Endocrinology & Metabolism

Safety issues in semen banks during the COVID-19 pandemic: data from a European survey

S. Marchiani, S. Dabizzi, S. Degl'Innocenti, M. G. Fino, M. G. Torcia, D. Paoli, F. Lombardo, N. Ciccone, S. Pollini, G. M. Rossolini, L. Vignozzi, C. Krausz, E. Baldi

Summary: European semen banks have implemented various measures to handle semen samples during the COVID-19 pandemic, but most centers did not adopt particularly drastic safety protocols. Nasopharyngeal swab testing is recommended to better manage couples undergoing assisted reproductive technology and to protect personnel.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Article Endocrinology & Metabolism

Management of male factor infertility: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) Endorsing Organization: Italian Society of Embryology, Reproduction, and Research (SIERR)

A. Ferlin, A. E. Calogero, C. Krausz, F. Lombardo, D. Paoli, R. Rago, C. Scarica, M. Simoni, C. Foresta, V Rochira, E. Sbardella, S. Francavilla, G. Corona

Summary: This article presents guidelines for the diagnosis, treatment, and management of male factor infertility, highlighting the importance of a couple-oriented approach and assessing risk factors.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Article Biochemistry & Molecular Biology

Epigenetic Effects of Gender-Affirming Hormone Treatment: A Pilot Study of the ESR2 Promoter's Methylation in AFAB People

Francesco Pallotti, Giulia Senofonte, Fani Konstantinidou, Silvia Di Chiano, Fabiana Faja, Flavio Rizzo, Francesco Cargnelutti, Csilla Krausz, Donatella Paoli, Andrea Lenzi, Liborio Stuppia, Valentina Gatta, Francesco Lombardo

Summary: Virilization of AFAB individuals through testosterone therapy can result in phenotypic changes, although inter-individual differences in timing and acquisition of characteristics are commonly observed. The study investigated the relationship between CpG methylation profiles of ESR2 and H19 promoters and their influence on phenotypic modifications in AFAB individuals undergoing testosterone therapy. Results showed a significant increase in methylation of the ESR2 promoter but not the H19 promoter after 6 and 12 months of treatment. Epigenetic changes appeared to be regulated and associated with patient age and testosterone levels. The study suggests that epigenetic regulation may play a role in phenotypical changes after testosterone treatment.

BIOMEDICINES (2022)

Article Andrology

Educational activities of the European Academy of Andrology

Emmanuele A. Jannini, Csilla Krausz

ANDROLOGY (2022)

Article Andrology

History of the European Academy of Andrology

Eberhard Nieschlag, Gianni Forti, Frederick Wu, Jorma Toppari, Csilla Krausz

ANDROLOGY (2022)

Article Andrology

ANDRONET: A new European network to boost research coordination, education and public awareness in andrology

Rafael Oliva, Csilla Krausz, Ewa Rajpert-De Meyts

ANDROLOGY (2022)

Article Multidisciplinary Sciences

Diverse monogenic subforms of human spermatogenic failure

Liina Nagirnaja, Alexandra M. Lopes, Wu-Lin Charng, Brian Miller, Rytis Stakaitis, Ieva Golubickaite, Alexandra Stendahl, Tianpengcheng Luan, Corinna Friedrich, Eisa Mahyari, Eloise Fadial, Laura Kasak, Katinka Vigh-Conrad, Manon S. Oud, Miguel J. Xavier, Samuel R. Cheers, Emma R. James, Jingtao Guo, Timothy G. Jenkins, Antoni Riera-Escamilla, Alberto Barros, Filipa Carvalho, Susana Fernandes, Joao Goncalves, Christina A. Gurnett, Niels Jorgensen, Davor Jezek, Emily S. Jungheim, Sabine Kliesch, Robert McLachlan, Kenan R. Omurtag, Adrian Pilatz, Jay Sandlow, James Smith, Michael L. Eisenberg, James M. Hotaling, Keith A. Jarvi, Margus Punab, Ewa Rajpert-De Meyts, Douglas T. Carrell, Csilla Krausz, Maris Laan, Moira K. O'Bryan, Peter N. Schlegel, Frank Tuettelmann, Joris A. Veltman, Kristian Almstrup, Kenneth Aston, Donald F. Conrad

Summary: In this study, exome-sequencing was conducted on over 1000 clinically diagnosed NOA cases, and a potential recessive Mendelian cause was identified in 20% of the cases. Integration with single-cell RNA sequencing data revealed different molecular subforms of azoospermia genes, including previously unrecognized subforms. This study highlights the importance of studying NOA as an understudied Mendelian disorder and provides a rational basis for understanding the complex genetics of male infertility.

NATURE COMMUNICATIONS (2022)

Article Oncology

Sperm DNA methylome abnormalities occur both pre- and post-treatment in men with Hodgkin disease and testicular cancer

Donovan Chan, Kathleen Oros Klein, Antoni Riera-Escamilla, Csilla Krausz, Cristian O'Flaherty, Peter Chan, Bernard Robaire, Jacquetta M. Trasler

Summary: This study aims to determine the impact of HD and TC and their treatments on sperm DNA methylation. The results show that imprinted gene methylation is not affected in sperm before or after treatment. However, sperm epigenetic defects are still evident in some cancer survivors up to 2 years post-treatment.

CLINICAL EPIGENETICS (2023)

Article Urology & Nephrology

Improved phenotypic classification of male infertility to promote discovery of genetic causes

Margot J. Wyrwoll, Godfried W. van der Heijden, Csilla Krausz, Kenneth I. Aston, Sabine Kliesch, Robert McLachlan, Liliana Ramos, Donald F. Conrad, Moira K. O'Bryan, Joris A. Veltman, Frank Tuettelmann

Summary: Discovering the genetic causes of non-syndromic male infertility and linking them with clinical data is crucial for better understanding the condition. The International Male Infertility Genomics Consortium has developed a standardized vocabulary based on the Human Phenotype Ontology (HPO) to facilitate communication and improve the classification of male infertility. This work will contribute to the systematic recording of patients' phenotypes and the discovery of novel genetic causes for non-syndromic male infertility.

NATURE REVIEWS UROLOGY (2023)

Review Andrology

EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: State of the art 2023

Csilla Krausz, Paulo Navarro-Costa, Martina Wilke, Frank Tuettelmann

Summary: Testing for AZoospermia Factor (AZF) deletions of the Y chromosome is crucial for diagnosing azoospermic and severely oligozoospermic men. This article summarizes recent advances in this field and provides an update on the external quality assessment program offered by the European Academy of Andrology (EAA) and EMQN CIC. The gold-standard method for detecting AZF deletions is a basic multiplex PCR reaction followed by a deletion extension analysis.

ANDROLOGY (2023)

No Data Available